Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00106093 · ClinicalTrials.gov registry record

Alcoholism Assessment and Treatment

A clinical trial, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Completed
Registry status
1,192
Enrollment target

NCT00106093: Completed study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

NCT00106093 is a clinical trial that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 1,192 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00106093 has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

COMPLETED
Registry status
1,192 participants
Enrollment target

Study Summary

The purpose of this study is to gather information about people s drinking histories and to evaluate them for other research studies being conducted at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The evaluation will include a physical examination, blood tests, an MRI scan of the brain and completion of various questionnaires about alcohol use and mood. The information gathered from all of these tests will be used by researchers to gain a better understanding of the disease of alcoholism and determine eligibility for other NIAAA studies. This is an inpatient study so participants will stay at the NIH hospital for at least three weeks and up to six weeks if a person is found to be eligible for other NIAAA research studies. The study is open to people age 18 and older whose alcohol drinking has caused significant problems in their lives, and who desire alcoholism treatment. Detoxification will be provided if needed, and each person may participate in our alcoholism treatment program. The treatment includes group and individual counseling sessions as well as self-help meetings such as AA. Family counseling and recreational opportunities are also an important part of the treatment experience. The doctors, nurses, social workers and all of our other staff are committed to helping participants design an aftercare program that will help them leave the hospital and remain sober. Participants may also be able to attend a 12-week aftercare program in the NIAAA outpatient clinic.

Trial Details

FieldValue
Enrollment Target 1,192 participants
Start Date 2005-03-16
Est. Completion 2015-09-08

What the finished NCT00106093 record still lists

NCT00106093 is an observational study that tracks outcomes without assigning an intervention. Its 1,192 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00106093 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00106093 about?

NCT00106093 is a clinical study titled "Alcoholism Assessment and Treatment". The purpose of this study is to gather information about people s drinking histories and to evaluate them for other research studies being conducted at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The evaluation will include a physical examination, blood tests, an MRI scan of the ...

What is the current status of trial NCT00106093?

This trial is currently completed. The enrollment target is 1,192 participants. The study started on 2005-03-16. Estimated completion is 2015-09-08.

Who is sponsoring clinical trial NCT00106093?

This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07177339 · 1,196 participants · Phase 3

    eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • NCT05580419 · 1,188 participants · NA

    Impact of 4PCP on Practitioner and Patient Outcomes

  • NCT06290869 · 1,188 participants · Phase 3

    Tobacco Education and Lung Health Study (TEAL)

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00106093, the US trial registry maintained by the National Library of Medicine. NCT00106093 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.